RBCs as a Bioinspired Drug Delivery System for Co-delivery of Irinotecan and Nanoalumina Enhances Colorectal Cancer Therapy
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.4c01396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Hongyu Zhong und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China. Hauptthemen laut MEDLINE: Irinotecan, Colorectal Neoplasms, Erythrocytes, Drug Delivery Systems. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Shanghai Jiao Tong University, National Natural Science Foundation of China, National Science and Technology Major Project.
Abstract (Originalsprache)
Colorectal cancer (CRC) is a malignant epithelial tumor with high morbidity and mortality. In CRC treatment, irinotecan (CPT-11) as a chemotherapeutic drug is widely applied. However, its half-life is short, leading to large dosages and severe side effects. Red blood cells (RBCs) are biocompatible drug carriers with high capacity, avoiding premature drug degradation and achieving slow drug release. Nanoalumina (AN) is an emerging immune adjuvant that can enhance the immune response. Here, we used RBCs as carriers and absorbed AN to construct AN-CPT-11-RBCs. CPT-11 would induce tumor cell death, releasing much tumor antigen, while AN would activate immune cells to recognize newly released antigens and induce lymphocyte proliferation, enhancing the antitumor effect simultaneously. With loading amounts of 4 mg of CPT-11 and 3 mg of AN per 109 RBCs, AN-CPT-11-RBCs had similar properties to natural RBCs. In vivo, AN-CPT-11-RBCs could circulate for 9 days and stimulate the proliferation of lymphocytes in the spleen and tumor tissue, having a higher tumor growth inhibition rate of 74.01% and a lower frequency of administration. In conclusion, AN-CPT-11-RBCs attain the co-delivery of CPT-11 and AN for the synergistic treatment of CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
ORCID-Profile: Faisal Raza, Jiyuan Xie, Mingfeng Qiu, Jing Su
Förderung
- Shanghai Jiao Tong University
- National Natural Science Foundation of China
- National Science and Technology Major Project
Zitieren
APA
Zhong, H., Li, Y., Raza, F., Xie, J., Rong, R., Qiu, M., & Su, J. (2025). RBCs as a Bioinspired Drug Delivery System for Co-delivery of Irinotecan and Nanoalumina Enhances Colorectal Cancer Therapy. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c01396
Vancouver
Zhong H, Li Y, Raza F, Xie J, Rong R, Qiu M, et al. RBCs as a Bioinspired Drug Delivery System for Co-delivery of Irinotecan and Nanoalumina Enhances Colorectal Cancer Therapy. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c01396
BibTeX
@article{Zhong2025,
author = {Zhong, Hongyu and Li, Yichen and Raza, Faisal and Xie, Jiyuan and Rong, Ruonan and Qiu, Mingfeng and Su, Jing},
title = {RBCs as a Bioinspired Drug Delivery System for Co-delivery of Irinotecan and Nanoalumina Enhances Colorectal Cancer Therapy},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.4c01396}
}
EUVIMED